Company Name:Sinovac Biotech Ltd.
CEO: Wei Dong Yin

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: CN

Description: Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.


Key numbers

Market Capitalization:460249273
Shares Outstanding: 71135900
Float: 38743883
Next Earning Date:
TTm EPS: 0.3161
TTm Dividend Rate:
200 days moving average:6.47
50 days moving average: 6.47
One day percent Change: 0



2017-06-30, 2017-12-31, 2018-06-30, 2018-12-31,
2017-06-30, 2017-12-31, 2018-06-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,